S. Claeyssens

1.3k total citations
39 papers, 793 citations indexed

About

S. Claeyssens is a scholar working on Hematology, Surgery and Molecular Biology. According to data from OpenAlex, S. Claeyssens has authored 39 papers receiving a total of 793 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 6 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in S. Claeyssens's work include Hemophilia Treatment and Research (14 papers), Platelet Disorders and Treatments (12 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). S. Claeyssens is often cited by papers focused on Hemophilia Treatment and Research (14 papers), Platelet Disorders and Treatments (12 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). S. Claeyssens collaborates with scholars based in France, United States and Switzerland. S. Claeyssens's co-authors include Hérvè Chambost, Thierry Calvez, Virginie Demiguel, Annie Borel‐Derlon, Jenny Goudemand, Thierry Lambert, Chantal Rothschild, Christine Vinciguerra, Y. Laurian and Natalie Stieltjes and has published in prestigious journals such as Blood, Cancer and British Journal of Haematology.

In The Last Decade

S. Claeyssens

35 papers receiving 754 citations

Peers

S. Claeyssens
Mannucci Italy
Roberta Guarnone Italy
S Barzegar United States
Martha C. Sola United States
Jean‐Louis Kerkhoffs Netherlands
C.L. Lutcher United States
Jonathan P. Wallis United Kingdom
L Revert Spain
Francesca Marangoni Italy
Simona Stancu Romania
Mannucci Italy
S. Claeyssens
Citations per year, relative to S. Claeyssens S. Claeyssens (= 1×) peers Mannucci

Countries citing papers authored by S. Claeyssens

Since Specialization
Citations

This map shows the geographic impact of S. Claeyssens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Claeyssens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Claeyssens more than expected).

Fields of papers citing papers by S. Claeyssens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Claeyssens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Claeyssens. The network helps show where S. Claeyssens may publish in the future.

Co-authorship network of co-authors of S. Claeyssens

This figure shows the co-authorship network connecting the top 25 collaborators of S. Claeyssens. A scholar is included among the top collaborators of S. Claeyssens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Claeyssens. S. Claeyssens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goudemand, Jenny, Sophie Susen, Claire Berger, et al.. (2025). Health-related quality of life in children with von Willebrand disease: results of the French real-life Willebrand Study Health-related Quality of Life study. Journal of Thrombosis and Haemostasis. 23(9). 2736–2750.
2.
Tardy, Brigitte, Thierry Lambert, Marc Trossaërt, et al.. (2022). Revised terminal half‐life of nonacog alfa as derived from extended sampling data: A real‐world study involving 64 haemophilia B patients on nonacog alfa regular prophylaxis. Haemophilia. 28(4). 542–547. 4 indexed citations
3.
Guillet, Benoît, Marianne Sigaud, S. Claeyssens, et al.. (2022). Prostate biopsy and prostate cancer management in patients with haemophilia: The experience of French Haemophilia Treatment Centres. Haemophilia. 28(3). 437–444. 1 indexed citations
4.
Goudemand, Jenny, Françoise Bridey, S. Claeyssens, et al.. (2020). Management of von Willebrand disease with a factor VIII‐poor von Willebrand factor concentrate: Results from a prospective observational post‐marketing study. Journal of Thrombosis and Haemostasis. 18(8). 1922–1933. 12 indexed citations
5.
Lienhart, Anne, S. Claeyssens, Catherine Ternisien, et al.. (2020). Identification of new F8 deep intronic variations in patients with haemophilia A. Haemophilia. 26(5). 847–854. 10 indexed citations
6.
Guillet, Benoît, Guillaume Cayla, Aurélien Lebreton, et al.. (2020). Long-Term Antithrombotic Treatments Prescribed for Cardiovascular Diseases in Patients with Hemophilia: Results from the French Registry. Thrombosis and Haemostasis. 121(3). 287–296. 20 indexed citations
7.
Négrier, Claude, A.‐S. Ducloy‐Bouthors, Vincent Piriou, et al.. (2017). Postauthorization safety study of Clottafact®, a triply secured fibrinogen concentrate in acquired fibrinogen deficiency: a prospective observational study. Vox Sanguinis. 113(2). 120–127. 8 indexed citations
8.
Dargaud, Yesim, Anna Pavlova, Sébastien Lacroix‐Desmazes, et al.. (2016). Achievements, challenges and unmet needs for haemophilia patients with inhibitors. Haemophilia. 22(S1). 1–24. 15 indexed citations
9.
Négrier, Claude, C. Rothschild, Jenny Goudemand, et al.. (2008). Pharmacokinetics and pharmacodynamics of a new highly secured fibrinogen concentrate. Journal of Thrombosis and Haemostasis. 6(9). 1494–1499. 30 indexed citations
10.
Stieltjes, Natalie, Thierry Calvez, Virginie Demiguel, et al.. (2005). Intracranial haemorrhages in French haemophilia patients (1991–2001): clinical presentation, management and prognosis factors for death. Haemophilia. 11(5). 452–458. 89 indexed citations
11.
Proust, Alexis, Benoît Guillet, Isabelle Pellier, et al.. (2005). Recurrent V75M mutation within the Wiskott–Aldrich syndrome protein: description of a homozygous female patient. European Journal Of Haematology. 75(1). 54–59. 7 indexed citations
12.
Lambert, Thierry, et al.. (2004). Intestinal surgery with activated recombinant factor VII prophylaxis in patients with haemophilia A and high responding inhibitors. Blood Coagulation & Fibrinolysis. 15(8). 687–691. 12 indexed citations
13.
Neerman‐Arbez, Marguerite, Philippe de Moerloose, Claire Bridel, et al.. (2000). Mutations in the fibrinogen aalpha gene account for the majority of cases of congenital afibrinogenemia.. Blood. 96(1). 149–52. 77 indexed citations
14.
Ljung, Rolf, Marijke van den Berg, Hérvè Chambost, et al.. (2000). Treatment of children with haemophilia in Europe: a survey of 20 centres in 16 countries. Haemophilia. 6(6). 619–624. 58 indexed citations
15.
Chaix, Yves, et al.. (1998). Pseudomaladie périodique avec hyperimmunoglobulinémie D: une histoire sans fin de début anténatal probable. Archives de Pédiatrie. 5(3). 280–284. 4 indexed citations
16.
Bouteloup‐Demange, Corinne, S. Claeyssens, Alain Lavoinne, Éric Lerebours, & Pierre Déchelotte. (1998). P.117Effect of an enteral glutamine supplementationon intestinal mucosal protein synthesis of hypercatabolic subjects. Clinical Nutrition. 17. 61–61. 2 indexed citations
17.
Rubie, H, Pierre Brousset, J. Guitard, et al.. (1996). Biopsie testiculaire à l'arrêt du traitement des leucémies aiguës lymphoblastiques: intérêt de la détection immunohistochimique des blastes résiduels. Archives de Pédiatrie. 3(10). 977–983. 1 indexed citations
18.
Collery, Philippe, Hervé Millart, D. Paillotin, et al.. (1995). Dose optimization of gallium chloride, orally administered, in combination with platinum compounds.. PubMed. 14(6A). 2299–306. 1 indexed citations
19.
Claeyssens, S., et al.. (1992). Metabolic changes during early starvation in rats fed a low-protein diet in the postweaning growth period. Metabolism. 41(7). 722–727. 8 indexed citations
20.
Claeyssens, S., et al.. (1990). Metabolic changes in rats fed a low protein diet during post-weaning growth. Metabolism. 39(7). 676–681. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mannucci Breakdown of academic impact, for papers by Roberta Guarnone Breakdown of academic impact, for papers by S Barzegar Breakdown of academic impact, for papers by Martha C. Sola Breakdown of academic impact, for papers by Jean‐Louis Kerkhoffs Breakdown of academic impact, for papers by C.L. Lutcher Breakdown of academic impact, for papers by Jonathan P. Wallis Breakdown of academic impact, for papers by L Revert Breakdown of academic impact, for papers by Francesca Marangoni Breakdown of academic impact, for papers by Simona Stancu
Rankless by CCL
2026